OJMM  Vol.2 No.4 , December 2012
Evaluation of Nitrate Reductase Assay for Rapid Detection of Drug Resistant Tuberculosis
ABSTRACT
Emergence of multidrug-resistant tuberculosis (MDR-TB) urgently demands for simple, rapid and inexpensive methods of its detection for the effective treatment of drug resistant tuberculosis, particularly in low-income countries. A total of 113 clinical isolates of M. tuberculosis were tested for four first line antitubercular drugs by nitrate reductase assay (NRA) and were compared with standard proportion method to evaluate NRA efficacy. Results were available in 7 - 14 days by NRA as compared to proportion method which generally takes 4 - 6 weeks. The sensitivity and specificity of NRA were 98.1% and 100% for isoniazid, 95.1% and 98.6% for rifampicin, 91.4% and 94.9% for streptomycin, and 78.6% and 97.9% for ethambutol, respectively. Agreement between NRA and proportion method were 99.1%, 97.3%, 93.8%, 95.6% for isoniazid, rifampicin, streptomycin and ethambutol, respectively. NRA is easier, inexpensive and reliable method for susceptibility testing of Mycobacterum tuberculosis for isoniazid and rifampicin, the two most im- portant drugs for the treatment of tuberculosis. The reduction in susceptibility testing time, and higher sensitivity and specificity of NRA method is of fundamental importance in detecting MDR-TB.

Cite this paper
R. Sah, D. Bhatta, G. Ghimire and J. Sherchand, "Evaluation of Nitrate Reductase Assay for Rapid Detection of Drug Resistant Tuberculosis," Open Journal of Medical Microbiology, Vol. 2 No. 4, 2012, pp. 138-141. doi: 10.4236/ojmm.2012.24021.
References
[1]   J. A. Caminero, “Multidrug-Resistant Tuberculosis: Epidemiology, Risk Factors and Case Finding,” International Journal of Tuberculosis and Lung Disease, Vol. 14, No. 4, 2010, pp. 382-390.

[2]   G. Canetti, W. Fox, A. Khomenko, H. T. Mahler, N. K. Menon, D. A. Mitchison, N. Rist and N. A. Smelev, “Advances in Techniques of Testing Mycobacterial Drug Sensitivity and the Use of Sensitivity Tests in Tuberculosis Control Programmes,” Bulletin of the World Health Organization, Vol. 41, No. 1, 1969, pp. 21-43.

[3]   G. D. Roberts, N. L. Goodman, L. Heifets, H. W. Larsh, T. H. Lindner, J. K. McClatchy, M. R. McGinnis, S. H. Siddiqi and P. Wright, “Evaluation of the BACTEC Radiometric Method for Recovery of Mycobacteria and Drug Susceptibility Testing of Mycobacterium Tuberculosis from Acid-Fast Smear-Positive Specimens,” Journal of Clinical Microbiology, Vol. 18, No. 3, 1983, pp. 689696.

[4]   L. Caviedes, J. Delgado and R. H. Gilman, “Tetrazolium Microplate Assay as a Rapid and Inexpensive Colorimetric Method for Determination of Antibiotic Susceptibility of Mycobacterium tuberculosis,” Journal of Clinical Microbiology, Vol. 40, No. 5, 2002, pp. 1873-1874. doi:10.1128/JCM.40.5.1873-1874.2002

[5]   S. G. Franzblau, R. S. Witzig, J. C. McLaughlin, P. Torres, G. Madico, A. Hernandez, M. T. Degnan, M. B. Cook, V. K. Quenzer, R. M. Ferguson and R. H. Gilman, “Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay,” Journal of Clinical Microbiology, Vol. 36, No. 2, 1998, pp. 362-366.

[6]   K. A. Angeby, L. Klintz and S. E. Hoffner, “Rapid and Inexpensive Drug Susceptibility Testing of Mycobacterium tuberculosis with a Nitrate Reductase Assay,” Journal of Clinical Microbiology, Vol. 40, No. 2, 2002, pp. 553-555. doi:10.1128/JCM.40.2.553-555.2002

[7]   E. Montoro, D. Lemus, M. Echemendia, A. Martin, F. Portaels and J. C. Palomino, “Comparative Evaluation of the Nitrate Reduction Assay, the MTT Test, and the Resazurin Microtitre Assay for Drug Susceptibility Testing of Clinical Isolates of Mycobacterium tuberculosis,” The Journal of Antimicrobial Chemotherapy, Vol. 55, No. 4, 2005, pp. 500-505. doi:10.1093/jac/dki023

[8]   P. T. Kent and G. P. Kubica, “Pubic Health Mycobacteriology: A Guide for the Level III Laboratory,” U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention, Atlanta, 1985, pp. 159-184.

[9]   World Health Organization, “The WHO/International Union against Tuberculosis and Lung Disease. Global Project on Anti-tuberculosis Drug Resistance Surveillance. Anti-Tuberculosis Drug Resistance in the World, Report No. 3,” World Health Organization, Geneva, 2004.

[10]   A. Martin, E. Montoro, D. Lemus, N. Simboli, N. Morcillo, M. Velasco, J. Chauca, L. Barrera, V. Ritacco, F. Portaels and J. C. Palomino, “Multicenter Evaluation of the Nitrate Reductase Assay for Drug Resistance Detection of Mycobacterium tuberculosis,” Journal of Microbiological Methods, Vol. 63, No. 2, 2005, pp. 145-150. doi:10.1016/j.mimet.2005.03.004

[11]   M. L. Shikama, R. R. Silva, M. C. Martins, C. M. Giampaglia, R. S. Oliveira, R. F. Silva, P. F. Silva, M. A. Telles, A. Martin and J. C. Palomino, “Rapid Detection of Resistant Tuberculosis by Nitrate Reductase Assay Performed in Three Settings in Brazil,” The Journal of Antimicrobial Chemotherapy, Vol. 64, No. 4, 2009, pp. 794796. doi:10.1093/jac/dkp284

[12]   D. Lemus, E. Montoro, M. Echemendia, A. Martin, F. Portaels and J. C. Palomino, “Nitrate Reductase Assay for Detection of Drug Resistance in Mycobacterium tuberculosis: Simple and Inexpensive Method for Low-Resource Laboratories,” Journal of Medical Microbiology, Vol. 55, No. 7, 2006, pp. 861-863. doi:10.1099/jmm.0.46540-0

[13]   A. Laszlo, M. Rahman, M. Espinal, M. Raviglione and the WHO/IUATLD Network of Supranational Reference Laboratories, “Quality Assurance Programme for Drug Susceptibility Testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: Five Round of Proficiency Testing, 1994-1998,” International Journal of Tuberculosis and Lung Disease, Vol. 6, No. 9, 2002, pp. 748-756.

 
 
Top